Astellas Venture Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 6
- Investments
- 89
- Portfolio
- 18
- Exits
- 49
Astellas Venture Management General Information
Description
Founded in 1999, Astellas Venture Management is the corporate venture arm of Astellas Pharma and is headquartered in Brisbane, California. The firm makes investment in privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development.
Contact Information
Website
www.astellasventure.com
Year Founded
2005
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 2000 Sierra Point Parkway
- Suite 500
- Brisbane, CA 94005
- United States
Astellas Venture Management Investments & Acquisitions (89)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mogrify | 04-May-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | 000000000 000000 |
| 000000000 | 23-Mar-2021 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | 000000000 000000 00.0 |
| 00000000 | 09-Mar-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000000000 000000 00.0 |
| 0000 000000000000 | 24-Feb-2021 | 00000 00000 | 0000 | Drug Delivery | Product Development | 000000000 000000 |
| 000000000 000 | 23-Nov-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 000000 00000 00.0 |
| 0000 00000000000 | 29-Oct-2020 | 000000000000 | 00000 | Monitoring Equipment | Generating Revenue | 0000000 000000 |
| 000000000 000 | 07-Sep-2020 | 00000 00000 | 0000 | Application Specific Semiconductors | Generating Revenue | 000000000 000000 00.0 |
| 00000000 000000000 | 26-Aug-2020 | 00000 00000 | Drug Discovery | Clinical Trials - Phase 1 | 000000000 000000 00.0 | |
| Heartseed | 11-Mar-2020 | Later Stage VC | Drug Discovery | Generating Revenue | 000000000 000000 | |
| TScan Therapeutics | 09-Jan-2020 | Early Stage VC | 0000 | Biotechnology | Generating Revenue/Not Profitable | 000000 00000 00.0 |
Astellas Venture Management Exits (49)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Viamet Pharmaceuticals Holdings | 10-Jan-2022 | Out of Business | |
| 00000000 000000000 | 26-Aug-2021 | 0000000 000000 | 00000 |
| 00000 000000000000 | 16-Jul-2021 | 000 | 00000 |
| 000000 000000 | 01-May-2021 | 000000000 00000000 | |
| 000000 00000000000 | 24-Feb-2021 | 000 00 00000000 | |
| 0000000 | 12-Feb-2021 | 000000 0000000000 | 0000 |
| 00000000 000000 | 05-Oct-2020 | 000 00 00000000 | |
| 0000000 | 02-Oct-2020 | 000 | 0000 |
| Innocrin Pharmaceuticals | 01-Oct-2019 | Out of Business | |
| Kanyos Bio | 11-Sep-2019 | Merger/Acquisition |
Astellas Venture Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAstellas Venture Management Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kazunori Maruyama Ph.D | President | 0 | 0 | 0 | Brisbane, CA |
| Hiromichi Kimura Ph.D | Investment Director | 0 | 0 | 0 | Brisbane, CA |
| Satoshi Konagai | Senior Investment Manager | Brisbane, CA | |||
| Tadayoshi Hirata | Senior Investment Manager | 0 | 0 | Brisbane, CA | |
| Hikaru Saito Ph.D | Senior Investment Manager | 0 | 0 | 0 | Brisbane, CA |
Astellas Venture Management Co-Investors (87)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| MPM Capital | 5 | 0 |
|
|
|
| Novartis Venture Fund | 0 | 0 | 0 |
|
|
| Osage University Partners | 0 | 0 | 0 |
|
|
| Abingworth Management | 0 | 0 | 0 |
|
|
| SV Health Investors | 0 | 0 |
|
|